IFNAR1 and plasma cell myeloma: The reason could be that sustained Type I IFN signaling is key for the expansion of LAG3+ Tregs, as it was shown that blocking type I IFNs receptor by IFNAR1 antibody hindered myeloma-driven LAG3+ Treg expansion11.